Subtype
Pancreatic Mucinous Cystic Neoplasm
CI-CAN-00001354Explore in graph →
Non-malignant8 active trials
Loading cancer entity…
Subtype
CI-CAN-00001354Explore in graph →
Clinical trials
45 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04291651 | UCSF PANC Cyst Registry(UCSF PCR) | recruiting | — | 4,000 | University of California, San FranciscoOTHER | 1 | Sep 22, 2026 | clinicaltrials |
| NCT04207944 | The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) | active not recruiting | Phase 2 | 100 | Duke UniversityOTHER | 1 | Sep 8, 2026 | clinicaltrials |
| NCT06276764 |
| The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas) |
| enrolling by invitation |
| — |
| 500 |
| Adenocyte, LLCINDUSTRY |
| 1 |
| Aug 6, 2026 |
| clinicaltrials |
| NCT03729453 | Intra-operative Pancreatoscopy in Patients With IPMN | active not recruiting | — | 100 | Boston Scientific CorporationINDUSTRY | 6 | Jul 24, 2026 | clinicaltrials |
| NCT07700992 | A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring(PANXEON) | recruiting | — | 600 | Università Vita-Salute San RaffaeleOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT07659639 | Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer(LASERBLOOD) | recruiting | N/A | 400 | Fondazione Policlinico Universitario Campus Bio-MedicoOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT03711890 | Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer | recruiting | N/A | 75 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07621029 | Venous Resection in Patients Undergoing Pancreatic Surgery(VENUS) | not yet recruiting | — | 1,000 | Sahlgrenska University HospitalOTHER | 2 | Jun 2, 2026 | clinicaltrials |
| NCT02757859 | WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer | active not recruiting | N/A | 845 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT06320990 | Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection(MCN_Tam) | recruiting | Phase 1 | 15 | University of NebraskaOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT07535125 | IPEX Study: Pancreatic Exocrine Insufficiency as a Functional Marker of Disease Progression in Patients With IPMN(IPEX) | not yet recruiting | — | 600 | A.O.U. Città della Salute e della ScienzaOTHER | 0 | Apr 16, 2026 | clinicaltrials |
| NCT04622423 | Advanced Therapies for Liver Metastases(LiMeT) | recruiting | — | 625 | IRCCS San RaffaeleOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT06712797 | Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center(PANTHER-PIC) | active not recruiting | N/A | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT02110498 | Early Detection of Pancreatic Cystic Neoplasms | completed | — | 3,000 | Johns Hopkins UniversityOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT07439757 | AI-Powered Precision Decision-Making for Pancreatic Diseases | recruiting | — | 2,000 | Changhai HospitalOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07262957 | Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)(PANENCA) | recruiting | Phase 4 | 400 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT06694792 | Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium(INCITE) | recruiting | — | 800 | IRCCS San RaffaeleOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT06519097 | Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3) | active not recruiting | Phase 2 | 4 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT07216521 | Intent of Surgery for IPMN | recruiting | — | 2,000 | NYU Langone HealthOTHER | 5 | Oct 14, 2025 | clinicaltrials |
| NCT06574373 | Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression | recruiting | — | 3,600 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT07117045 | Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer(AI-LDCT-PC) | recruiting | — | 400,000 | Changhai HospitalOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT02070705 | DCE MRI in Patients With Pancreatic Cancer | terminated | N/A | 77 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT07014709 | Impact of GLP-1 Receptor Agonists on Patients With IPMN(IPMN-GLP1RA) | not yet recruiting | — | 30 | Hôpital FribourgeoisOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06638866 | AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort(AI-PANC) | recruiting | — | 5,000 | Changhai HospitalOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06570174 | Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients | completed | N/A | 60 | Yonsei UniversityOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT06283576 | Pancreatic Cancer Initial Detection Via Liquid Biopsy(PANCAID) | enrolling by invitation | — | 200 | Karolinska University HospitalOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT05117723 | Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer(MAPS) | recruiting | — | 1,000 | St Vincent's Hospital MelbourneOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT05433935 | Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas | recruiting | — | 5,000 | Zhejiang UniversityOTHER | 1 | Jan 27, 2023 | clinicaltrials |
| NCT05593393 | A Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous Neoplasm | unknown | — | 1,500 | Peking Union Medical College HospitalOTHER | 0 | Nov 14, 2022 | clinicaltrials |
| NCT03731819 | Establishment of Abbreviated Pancreatobiliary MRI Protocol | completed | N/A | 30 | Seoul National University HospitalOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT01643460 | Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts | completed | N/A | 33 | Indiana UniversityOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT03188991 | Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms | completed | Phase 2 | 20 | NanOlogy, LLCINDUSTRY | 1 | Jun 14, 2021 | clinicaltrials |
| NCT03062124 | SpyGlass in Preoperative Diagnostics of Presumed Main Duct IPMNs: Efficacy and Novel Insights on Complications | completed | — | 101 | Helsinki University Central HospitalOTHER | 2 | May 20, 2021 | clinicaltrials |
| NCT02523170 | A Phase II MULTICENTRE Trial of Needle Based Laser Confocal Endomicroscopy of Cystic and Solid Tumours of the Pancreas(CONCYST) | completed | N/A | 67 | University College, LondonOTHER | 1 | Oct 2, 2019 | clinicaltrials |
| NCT03520153 | Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome | withdrawn | — | 0 | Yale UniversityOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT03884179 | Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy | unknown | — | 58 | Sahlgrenska University HospitalOTHER | 0 | Mar 21, 2019 | clinicaltrials |
| NCT03838913 | Whole-Exome Sequencing (WES) of Intraductal Neoplasms of the Bile Duct (IPNB)(WESIPNB) | unknown | — | 60 | Fujian Provincial HospitalOTHER | 1 | Feb 12, 2019 | clinicaltrials |
| NCT02494388 | Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions(CINE-Cyst) | terminated | — | 10 | University of Medicine and Pharmacy CraiovaOTHER | 4 | Jan 17, 2018 | clinicaltrials |
| NCT00689715 | Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas(EUS-EP) | unknown | Phase 2 / Phase 3 | 50 | Asan Medical CenterOTHER | 1 | Jul 26, 2016 | clinicaltrials |
| NCT00988416 | Positron Emission Tomography-computed Tomography (PET-CT) for Main & Branch Intraductal Papillary Mucinous Neoplasm | completed | — | 69 | Indiana UniversityOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT01094626 | Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection | withdrawn | N/A | 0 | Elizabeth HechtOTHER | 0 | Jun 10, 2016 | clinicaltrials |
| NCT02213419 | Endoscopic Ultrasonography-guided Double Ethanol Lavage for Pancreatic Cysts: a Prospective Cohort Study | unknown | Phase 1 | 40 | Samsung Medical CenterOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT00482625 | Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | Oct 16, 2014 | clinicaltrials |
| NCT00621556 | Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas | terminated | Phase 1 | 2 | Massachusetts General HospitalOTHER | 1 | Jan 29, 2009 | clinicaltrials |
Data updated 5 days agoSource updated Sep 22, 2026source: clinicaltrials